Yep, UBER is a software based model which allows for a much higher valuation premium than a hardware provider of a soon to be commodity product that cannot block competition from coming in and killing gross margins.
Ask yourself what PE multiples all of the iphone parts suppliers enjoy and then compare this company to that. That is more of a apples to apples comparison and it would put AMBA's price at closer to $30-$60/share.
So its even worse than people think.
After plummeting from $8. OREX just a few days back did 7 clear bounces off of $4.80 before it finally punched down through it hard to $4.30.
What was your point again?
I remember that big fight in VVUS about firing CEO's and the like just like ARNA is starting to do now.
Typical human survival behavior when sh !! !T is about to hit the fan.
With the current rate of flat script growth it would even be difficult to defend a 500 million valuation.
The problem is simply that Americans do not really care about losing weight and the true obesity market is much much smaller than everyone thought.
Has TEVA officially filed for a Contrave ANDA with the FDA yet? Because that's coming down the pipe too and realistically I don't see Orex winning against the generic drug makers in their suit.
Script growth has also reversed so expect a BIG earnings miss for Q2 and expect some big downward earnings revisions coming soon.
Your god doesn't even exist you terrorist nutto head. Electing leaders who believe in delusions is generally not a good thing. Just look at the middle east where religious rule is the law. Believing delusions is ALWAYS bad. Always.
Clearly, the only persons spinning here are the longs where joseph lied and accused me of spinning last weeks numbers and now you accuse me of spinning this weeks numbers. HILARIOUS! Instead of constantly looking for excuses I would counsel you to consider that revealing that your drug has a higher death rate than placebo is actually hurting prescriptions. OREX lost more scripts than all the other weight loss drugs this past week, why?. And OREX lost 400 scripts in the week before that, why?. And OREX gained the least amount of scripts (only 100) in the week before that, why?
The answer is right in front of you if you'd just remove your beer goggles and biases, you would see it.
In a span of 3 weeks, OREX has gone from the best weekly performing obesity drug............to now the worst weekly performing and that just happens to coincide exactly with the very poor 50% data release.
The only person spinning are the longs where joseph lied and accused me of spinning last weeks numbers and now you accuse me of spinning this weeks numbers. HILARIOUS! Instead of constantly looking for excuses I would counsel you to consider that revealing that your drug has a higher death rate than placebo will actually hurt prescriptions. OREX lost more scripts than all the other weight loss drugs this past week, why?. And OREX lost 400 scripts in the week before that, why?. And OREX gained the least amount of scripts (only 100) in the week before that, why?
The answer is right in front of you if you'd just remove your beer goggles.
First you should understand that OREX was in the 3's and heading lower when OREX shot up due to funds getting leaked the 25% data in the first place. Now that the 25% data has been proven fake and that it's more likely OREX increases the risk of death, you should fully expect OREX to retest those lows in the 3's. Anyone holding here is just asking to lose their money IMO. Better to buy around $3.40 with a stop and then hope it bounces off it's 2014 lows.
The decline is real now as OREX has put in its first ever multiweek decline.
Only an idiot or the naive would think that the horrible health data from the cancelled study would not give doctors pause to prescribe Contrave. No way no how can OREX justify their bloated 600 million mkcap so you better get out now before the fund managers beat you to it and you wake up with OREX at 2 bucks.
A massive drop of 2100 scripts for this past week means May is the month OREX scripts turned negative. OREX has now dropped a collective 2400 scripts since the study was cancelled and the Nissen revealed the truth that Contrave has a higher death rate than placebo.
This has gone from bad to worse now!
On the midweek 50% data dump scripts only gained a measly 100 scripts. The next week they dropped 400 scripts and this week will be weak again even with the extra day and the previously usual odds of a strong comeback week after a previous poor showing.
The drug only lowers weight 4% for the majority of users and it might raise your death risk a big 16% given that 102 people taking the placebo drug died while 116 people who were actively taking Contrave died! Doctors error to cause no harm and they have already begun migrating their patients away from Contrave.
Go look at the script chart and the next time Spencer posts the chart, this time pay close attention to the distinct change in Contrave trendline that begins immediately after the 50% heat data was released. Sorry you are so emotional that it clouds your judgement but this stock is about to do a VVUS type decline very soon based simply on declining fundamentals.
Last week Contrave posted one of it worst weekly drops ever and they have never had 2 bad weekly drops in a row since launch. But since the bad heart data has caused Docs to stop prescribing Contrave, tomorrow will mark the very first time scripts have dropped 2 weeks in a row as the new trend is now shrinkage, not growth.
Anyone able to sell above $5 is getting a true gift since noone has figured this out yet. Except me. :)
Institutional exit has begun and will ramp up in earnest beginning next wed-friday. Good luck to the pot committed who refuse to sell when the information changes.
A substantial portion of Forbes' revenue is from "article for hire schemes" like this one. It should be illegal and possibly is, but it is how the world has become. Pay to play!
There are some very powerful, rich and corrupt people who are deadset on destroying AMRN. This was evident in their FDA hearing that was closer to a sham show trial than anything else. The next move was to delay NCE as long as possible and let AMRN starve.
Even with the ruling, today's complete fabrication of a news article by Forbes proves that those same corrupt players are still deadset on AMRN's destruction.
Just remember, you can be right.....and still go broke. Be very careful here.